Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03427541
NCT03427541
Unknown
Not Applicable

A Multi-centre Real-world Non-interventional Observational Study to Explore Prognoses of the Patients With Non-small Cell Lung Cancer Complicated With Oligometastases

Tang-Du Hospital10 sites in 1 country1,000 target enrollmentDecember 31, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsNon Small Cell Lung Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Non Small Cell Lung Cancer
Sponsor
Tang-Du Hospital
Enrollment
1000
Locations
10
Primary Endpoint
Overall survival
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

An observational study to explore prognoses and clinical treatments of the patients with non-small cell lung cancer complicated with oligometastases

Detailed Description

A multi-centre real-world non-interventional observational study to explore prognoses and clinical treatments of the patients with non-small lung cancer complicated with oligometastases

Registry
clinicaltrials.gov
Start Date
December 31, 2017
End Date
April 30, 2018
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tang-Du Hospital
Responsible Party
Principal Investigator
Principal Investigator

Zhang Helong

Professor

Tang-Du Hospital

Eligibility Criteria

Inclusion Criteria

  • •Pathologically diagnosed patients with non-small cell lung cancer;
  • •Tumor metastases in one organ (no more than 3 metastases);

Exclusion Criteria

  • •Patients with intrapulmonary metastases or multiple primary tumors;
  • •Patients with pleural dissemination or invasion of extrapulmonary organs;
  • •Patients with supraclavicular lymph node metastasis;
  • •Patients with systematic diseases that would influence patient survivals;
  • •Patients with no records for visits;

Outcomes

Primary Outcomes

Overall survival

Time Frame: 2014 - 2017

Overall survival

Secondary Outcomes

  • Disease-free survival(2014 - 2017)

Study Sites (10)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With AlectinibNSCLC
NCT04764188Hoffmann-La Roche800
Completed
Not Applicable
A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC PatientsNon-small Cell Lung Cancer
NCT03429673China-Japan Friendship Hospital10,885
Unknown
Not Applicable
A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine FibroidsUterine Fibroids
NCT01635452PregLem SA1,500
Completed
Not Applicable
Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)Renal Cell Carcinoma
NCT05650164Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany171
Completed
Not Applicable
A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in GreeceAdvanced Soft Tissue Sarcoma
NCT02618122Genesis Pharma S.A.63